摘要
目的探讨在骨髓增生异常综合征治疗中应用地西他滨的效果。方法对我院近年来收治的46例骨髓增生异常综合征患者进行回顾性分析,依据患者入院就诊时间分为参照组与实验组,每组患者例数23例,参照组治疗中实行常规HA方案疗法,实验组治疗中予以地西他滨,对比两组患者并发症发生率与治疗效果。结果实验组患者有效率是95.65%、并发症发生率为4.34%,均优于参照组的有效率65.21%、并发症发生率26.08%,P<0.05,差异有统计学意义。结论将地西他滨疗法应用在骨髓增生异常综合征中具有显著效果,可以降低并发症发生率,改善治疗效果。
Objective To study the application in the treatment of myelodysplastic syndrome the effect of decitabine. Methods 46 cases of myelodysplastic syndrome were retrospectively analyzed in our hospital, on the basis of treatment time of patients admitted into control group and experimental group, each group with 23 cases, according to the implementation of conventional HA scheme in the treatment of treatment group, the experimental group in the treatment of decitabine, were compared between the two groups the occurrence rate of complications and treatment effect. Results The effective rate of the experimental group was 95.65%, the incidence of complications was 4.34%, the effective rate of the reference group was 65.21%, the incidence of complications was 26.08%, P〈0.05, the difference was statistically significant. Conclusion The application of the treatment of the western medicine in the treatment of patients with bone marrow hyperplasia has a significant effect, which can reduce the incidence of complications and improve the treatment effect.
出处
《中国继续医学教育》
2016年第30期136-137,共2页
China Continuing Medical Education
